These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18221139)

  • 1. Inhibition of HIV-1 entry into cells.
    Copeland KF
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):107-12. PubMed ID: 18221139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viral entry as therapeutic target. Current situation of entry inhibitors].
    Arenzana-Seisdedos F
    Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 11():5-11. PubMed ID: 19133215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine antagonists as therapeutics: focus on HIV-1.
    Tsibris AM; Kuritzkes DR
    Annu Rev Med; 2007; 58():445-59. PubMed ID: 16958560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV entry inhibitors revisited.
    Leonard JT; Roy K
    Curr Med Chem; 2006; 13(8):911-34. PubMed ID: 16611075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in HIV-1 entry inhibitors: strategies to interfere with receptor and coreceptor engagement.
    Markovic I
    Curr Pharm Des; 2006; 12(9):1105-19. PubMed ID: 16515489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of viral entry.
    Melby T; Westby M
    Handb Exp Pharmacol; 2009; (189):177-202. PubMed ID: 19048201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV entry into the cells--mechanisms and therapeutic possibilities].
    Briz V; Poveda E; Soriano V
    Med Clin (Barc); 2006 Mar; 126(9):341-8. PubMed ID: 16650368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 entry and its inhibition.
    Pierson TC; Doms RW
    Curr Top Microbiol Immunol; 2003; 281():1-27. PubMed ID: 12932074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Entry and Membrane Fusion Inhibitors.
    Xiao T; Cai Y; Chen B
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33922579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New kinds of AIDS drugs inhibit HIV entry into the cell. Entry inhibitors soon for oral administration].
    Fätkenheuer G
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():46-8. PubMed ID: 16385874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drug targets for antiretroviral therapy.
    Reeves JD; Piefer AJ
    Drugs; 2005; 65(13):1747-66. PubMed ID: 16114975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV entry inhibitors: progress in development and application.
    Lai WH; Huang L; Chen CH
    Yao Xue Xue Bao; 2010 Feb; 45(2):131-40. PubMed ID: 21348414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular entry of HIV: Evaluation of therapeutic targets.
    Pöhlmann S; Reeves JD
    Curr Pharm Des; 2006; 12(16):1963-73. PubMed ID: 16787241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upcoming drugs that inhibit viral entry will be a new frontier for antiretroviral therapy.
    Murphy MJ
    HIV Clin; 2002; 14(4):1-3. PubMed ID: 12434756
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a future for antiviral fusion inhibitors?
    Berkhout B; Eggink D; Sanders RW
    Curr Opin Virol; 2012 Feb; 2(1):50-9. PubMed ID: 22440966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapies based on mechanisms of HIV-1 cell entry.
    Kilby JM; Eron JJ
    N Engl J Med; 2003 May; 348(22):2228-38. PubMed ID: 12773651
    [No Abstract]   [Full Text] [Related]  

  • 17. Virus entry as a target for anti-HIV intervention.
    Esté JA
    Curr Med Chem; 2003 Sep; 10(17):1617-32. PubMed ID: 12871111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update in the development of HIV entry inhibitors.
    Rusconi S; Scozzafava A; Mastrolorenzo A; Supuran CT
    Curr Top Med Chem; 2007; 7(13):1273-89. PubMed ID: 17627557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics, interactions and mechanism of action of maraviroc].
    Soriano V; Poveda E
    Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 11():12-6. PubMed ID: 19133216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of resistance and failure of treatment with maraviroc].
    Delgado R
    Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 11():28-33. PubMed ID: 19133219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.